Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (57)

2024

  1. Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 421-433

2023

  1. Executive summary of the expert consensus document from the Spanish Society of Neurosurgery and the Spanish Society of Endocrinology and Nutrition: Clinical recommendations on the perioperative management of pituitary tumors

    Neurocirugia, Vol. 34, Núm. 6, pp. 292-307

  2. Executive summary of the expert consensus document from the Spanish Society of Neurosurgery and the Spanish Society of Endocrinology and Nutrition: Clinical recommendations on the perioperative management of pituitary tumors

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 9, pp. 592-608

  3. Hypopituitarism after traumatic brain injury in adults: Clinical guidelines of the neuroendocrinology area of the Spanish Society of Endocrinology and Nutrition (SEEN)

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 9, pp. 584-591

2022

  1. Acromegaly disease activity according to ACRODAT®, a cross-sectional study in Spain: ACROVAL study

    Endocrine, Vol. 75, Núm. 2, pp. 525-536

  2. Data mining analyses for precision medicine in acromegaly: a proof of concept

    Scientific Reports, Vol. 12, Núm. 1

  3. Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain

    Frontiers in Endocrinology, Vol. 13

  4. Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response

    Biomedicines, Vol. 10, Núm. 2

2021

  1. Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain

    Neuroendocrinology, Vol. 111, Núm. 10, pp. 925-936

  2. Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas

    Clinical Endocrinology, Vol. 94, Núm. 5, pp. 811-819

  3. Pituitary surgery in elderly patients: a safe and effective procedure

    Endocrine, Vol. 72, Núm. 3, pp. 814-822

2020

  1. GFRα 1-2-3-4 co-receptors for RET Are co-expressed in Pituitary Stem Cells but Individually Retained in Some Adenopituitary Cells

    Frontiers in Endocrinology, Vol. 11

  2. GLP1 Receptor Agonist and SGLT2 Inhibitor Combination: An Effective Approach in Real-world Clinical Practice

    Clinical Therapeutics, Vol. 42, Núm. 2, pp. e1-e12

  3. Molecular profiling for acromegaly treatment: a validation study

    Endocrine-related cancer, Vol. 27, Núm. 6, pp. 375-389

2017

  1. Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer

    Oncogene, Vol. 36, Núm. 5, pp. 652-666

  2. The Effect of the Exon-3-Deleted Growth Hormone Receptor on Pegvisomant-Treated Acromegaly: A Systematic Review and Meta-Analysis

    Neuroendocrinology, Vol. 105, Núm. 2, pp. 131-140

2016

  1. Enfermedades de las glándulas adrenales. Insuficiencia suprarrenal primaria

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 14, pp. 775-780

  2. Feocromocitoma y paraganglioma

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 14, pp. 795-801

  3. Genetic Predictors of Response to Different Medical Therapies in Acromegaly

    Progress in Molecular Biology and Translational Science (Elsevier B.V.), pp. 85-114

  4. Hiperaldosteronismo e hipoaldosteronismo

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 14, pp. 787-794